• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 211/14 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Patent holdings for IPC class C07D 211/14

Total number of patents in this class: 400

10-year publication summary

26
27
22
26
30
24
29
26
31
10
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Nocion Therapeutics, Inc.
51
9
Bristol-myers Squibb Company
4742
7
Incyte Corporation
1071
7
University of Pittsburgh - Of the Commonwealth System of Higher Education
3304
7
Centre National de La Recherche Scientifique
11023
6
Incyte Holdings Corporation
624
6
Massachusetts Institute of Technology
10251
5
BASF SE
21303
4
Janssen Pharmaceutica N.V.
3168
4
Immunomet Therapeutics Inc.
31
4
Toyama Chemical Co., Ltd.
88
4
Anji Pharmaceuticals Inc.
31
4
Etherna Immunotherapies NV
66
4
Vividion Therapeutics, Inc.
43
4
Grey Wolf Therapeutics Limited
17
4
Cassava Science, Inc.
14
4
Chevron U.S.A. Inc.
4140
3
JSR Corporation
2554
3
Chong Kun Dang Pharmaceutical Corp.
250
3
Electrophoretics Limited
84
3
Other owners 305